Mast pharmaceuticals

Other than the therapeutic antibodies, which target the IgE allergic pathway, immune factors, and CD4, Tanox also possessed several other major patented technologies. Among those, two sets of patents represent landmark inventions in their respectively related fields. Largely because these patents were awarded too far ahead the maturation of the peripheral technologies, they did not bring material financial impact on Tanox. Nonetheless, the creation of these technologies helped germinate the two important fields and enhanced Tanox as a pioneer in the antibody field.

https:///content/mast-cell-disorders “Mast Cell Activated Disorders” These disorders include these symptoms- 1) Wheezing/pulmonary signs and symptoms -Asthma, Anaphylaxis, Carcinoid tumors. 2) Hives/itching/rash- Atopic dermatosis, Chronic urticaria, Angioedema, Scleroderma, 3) Autoimmune disorders- Vasculitis, Diarrhea/abdominal pain, Allergic reaction to food, Eosinophilic GI disorders, Celiac disease, IBS, VIPoma
4) Hematologic disorders- Myelodysplastic syndrome/myeloproliferative neoplasms, Chronic eosinophilic leukemia. (So, lower these symptoms with a histamine free diet and colostrum/lactoferrin.)

Mast pharmaceuticals

mast pharmaceuticals


mast pharmaceuticalsmast pharmaceuticalsmast pharmaceuticalsmast pharmaceuticalsmast pharmaceuticals